We have studies that show exercise for older women is very beneficial; new study shows benefits for the young.
Read More »GLP-1 Receptor Agonist vs Insulin: Mortality Rate and Cardiovascular Risk
Does insulin cause more deaths and cardiovascular outcomes than GLP-1 agonist receptors?
Read More »Lowering LDL with the New PCSK9 Inhibitors
In part 3 of this exclusive interview, Dr. Eckel discusses the new PCSK9 Inhibitors and their LDL-lowering effects, and why they are beneficial for statin-intolerant patients.
Read More »Effect of Lipid Lowering Drugs on Type 2 Diabetes
ETC-1002 may offer new therapeutic option that does not decrease glycemic control.
Read More »Diabetes, Kidney Problems and Cardiovascular Risk in Minority Patients
Prevalence of early CKD higher among Hispanics and African Americans.
Read More »Exercising and Cardiovascular Risk
Is moderate exercising helping or hurting cardiovascular outcomes?
Read More »High Cholesterol: a Silent Killer that Needs Immediate Attention
Is high cholesterol associated with risk of type 2, cardiovascular diseases and high mortality rates?
Read More »JUST 30 MINUTES : Dramatic Decrease in AF With Cardio Fitness
Exercise shown to have some AFib-specific benefits.
Read More »The Safest First-Line Therapy for Type 2 Diabetes
According to more than 200 studies involving 1.4 million patients, metformin reduces heart disease risk in diabetes patients more effectively than its competitors.
Read More »New GLP-1 Drug Shows Cardiovascular Benefit
This is the fourth drug to treat diabetes that also can reduce the risk of heart disease.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.